Compounds > lonafarnib
Page last updated: 2024-09-04

lonafarnib and cx 4945

lonafarnib has been researched along with cx 4945 in 1 studies

Compound Research Comparison

Studies
(lonafarnib)		Trials
(lonafarnib)		Recent Studies (post-2010)
(lonafarnib)		Studies
(cx 4945)		Trials
(cx 4945)		Recent Studies (post-2010) (cx 4945)
22434901662162

Protein Interaction Comparison

ProteinTaxonomylonafarnib (IC50)cx 4945 (IC50)
Death-associated protein kinase 3Homo sapiens (human)0.017
G2/mitotic-specific cyclin-B2Homo sapiens (human)0.056
Cyclin-dependent kinase 1Homo sapiens (human)0.056
Serine/threonine-protein kinase pim-1Homo sapiens (human)0.0465
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.056
Casein kinase II subunit alpha'Homo sapiens (human)0.1316
G1/S-specific cyclin-E1Homo sapiens (human)1.8
Cyclin-dependent kinase 2Homo sapiens (human)1.8
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.0417
Casein kinase I isoform alphaHomo sapiens (human)0.004
Casein kinase I isoform deltaHomo sapiens (human)0.004
Casein kinase I isoform epsilonHomo sapiens (human)0.004
Dual specificity protein kinase CLK1Homo sapiens (human)0.012
Dual specificity protein kinase CLK2Homo sapiens (human)0.0039
Dual specificity protein kinase CLK3Homo sapiens (human)0.041
Casein kinase II subunit betaHomo sapiens (human)0.2833
Casein kinase II subunit alphaHomo sapiens (human)0.1968
Casein kinase I isoform gamma-2Homo sapiens (human)0.004
Dual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)0.0069
Casein kinase II subunit alpha 3Homo sapiens (human)0.2516
G2/mitotic-specific cyclin-B3Homo sapiens (human)0.056
Homeodomain-interacting protein kinase 3Homo sapiens (human)0.045
Dual specificity protein kinase CLK4Homo sapiens (human)0.011
Casein kinase I isoform gamma-1Homo sapiens (human)0.004
Serine/threonine-protein kinase pim-2Homo sapiens (human)0.186
Serine/threonine-protein kinase TBK1Homo sapiens (human)0.035
Dual specificity tyrosine-phosphorylation-regulated kinase 1BHomo sapiens (human)0.0064

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Laufer, S; Pillaiyar, T1

Reviews

1 review(s) available for lonafarnib and cx 4945

ArticleYear
Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy.
    Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2

    Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Protein Kinase Inhibitors; SARS-CoV-2; Signal Transduction; Virus Replication

2022